[SYRS] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
14-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 40.18%
YoY- 19.11%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 2,833 2,954 -5,467 3,891 6,276 5,467 7,802 -49.19%
PBT -36,258 -23,789 -4,774 -30,253 -34,481 -25,146 -23,813 32.45%
Tax 1,278 -8,865 -32,349 -9,201 712 -1,507 986 18.93%
NP -36,258 -14,924 27,575 -21,052 -35,193 -23,639 -23,813 32.45%
Tax Rate - - - - - - - -
Total Cost 39,091 17,878 -33,042 24,943 41,469 29,106 31,615 15.24%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -1,279.84 -505.21 -504.39 -541.04 -560.76 -432.39 -305.22 160.71%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -1.30 -0.54 0.99 -2.24 -5.51 -3.75 -3.78 -51.00%
EPS Diluted -1.30 -0.54 0.99 -2.24 -5.51 -3.75 -3.78 -51.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.